Menu
Not yet recruiting NCT07023913

Effect of Kinetic Control Exercise on Shoulder Dysfunction Post Mastectomy

No phase Interventional Kinetic Control Dysfunction Shoulder Mastectomy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: kinetic Control exercises, traditional treatment.
Who it may be relevant to
Registry conditions: Kinetic Control, Dysfunction, Shoulder, Mastectomy. Basic parameters: 40 years — 50 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The purpose of this study is to evaluate the effect of kinetic control exercises on shoulder dysfunction in post-mastectomy.

Detailed description

This study holds significant importance for clinical practice, patient care, and research.

* Clinical Practice: It provides a potential framework for physical therapists to design targeted and effective interventions for shoulder dysfunction in post-mastectomy patients. * Patient Care: Improved rehabilitation outcomes can enhance patients' physical functionality, independence, and overall quality of life, addressing a critical gap in post-operative recovery. * Research Advancement: By contributing to the limited body of literature on kinetic control in this context, the study can stimulate further research and innovation in rehabilitative care for breast cancer survivors.

Interventions

  • Other kinetic Control exercises
    Kinetic Control exercises consist of 45-minute sessions, with 3 sessions per week for 8 weeks. The framework for testing and rehabilitation includes initial assessment, rehabilitation before failure, and retesting the same position. Biofeedback measures scapular retraction, and biofeedback pressure training assesses and improves scapular stabilizer control by monitoring pressure changes during specific movements.
  • Other traditional treatment
    traditional therapy inform of stretching and strengthening exercise as shoulder roll, arm circle, wall climb, back climb and hand behind neck. Patients will receive 3 sessions per week for 8 weeks, the time of session is 45 - 60 min according to patient ability

Primary outcome measures

  • assessment of change of range of motion [Time frame: at baseline and after 8 weeks]
Secondary outcome measures (2)
  • assessment of ability to maintain controlled shoulder movements while stabilizing the scapular and shoulder [Time frame: at baseline and after 8 weeks]
  • assessment of ability to maintain controlled shoulder movements while stabilizing the scapular and shoulder [Time frame: at baseline and after 8 weeks]

Eligibility criteria

Inclusion criteria

The subject selection will be according to the following criteria:

  • Age from 40 to 50 years.
  • All patients have no diabetes or blood problems.
  • All patients enrolled to the study will have their informed consent.

Exclusion criteria

The potential participants will be excluded if they meet one of the following criteria:

  • Age less than 40 or more 50 years.
  • Diabetes mellitus.
  • Subjects with lymphedema
  • Subjects suffering from active malignant tumors.
  • Subjects treated with skin graft.
  • Subjects with Mental illness.
  • Subjects with skin diseases
  • Subjects with any previous cause for shoulder dysfunction

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • learning hospitals Al Kaser Al Ayni hospital — Cairo

Identifiers

NCT: NCT07023913 · Alaa-005696

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗